ITeos Therapeutics Inc (NASDAQ: ITOS) Is Currently -127.83 Percent Below Its 52-Week High, But It Still Offers Strong Upside Potential.
ITeos Therapeutics Inc (NASDAQ:ITOS)’s traded shares stood at 1.05 million during the last session, with the company’s beta value hitting 1.38. At the close of